Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 240

1.

A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.

Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F617-27. Epub 2006 Oct 3.

2.

Inhibition of glucokinase translocation by AMP-activated protein kinase is associated with phosphorylation of both GKRP and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.

Mukhtar MH, Payne VA, Arden C, Harbottle A, Khan S, Lange AJ, Agius L.

Am J Physiol Regul Integr Comp Physiol. 2008 Mar;294(3):R766-74. doi: 10.1152/ajpregu.00593.2007. Epub 2008 Jan 16.

3.

AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling.

Bolster DR, Crozier SJ, Kimball SR, Jefferson LS.

J Biol Chem. 2002 Jul 5;277(27):23977-80. Epub 2002 May 7.

4.
5.

Hydrogen sulfide inhibits high glucose-induced matrix protein synthesis by activating AMP-activated protein kinase in renal epithelial cells.

Lee HJ, Mariappan MM, Feliers D, Cavaglieri RC, Sataranatarajan K, Abboud HE, Choudhury GG, Kasinath BS.

J Biol Chem. 2012 Feb 10;287(7):4451-61. doi: 10.1074/jbc.M111.278325. Epub 2011 Dec 9.

6.

AMP-activated protein kinase in metabolic control and insulin signaling.

Towler MC, Hardie DG.

Circ Res. 2007 Feb 16;100(3):328-41. Review.

8.

AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions.

Thomson DM, Fick CA, Gordon SE.

J Appl Physiol (1985). 2008 Mar;104(3):625-32. doi: 10.1152/japplphysiol.00915.2007. Epub 2008 Jan 10.

9.

A possible linkage between AMP-activated protein kinase (AMPK) and mammalian target of rapamycin (mTOR) signalling pathway.

Kimura N, Tokunaga C, Dalal S, Richardson C, Yoshino K, Hara K, Kemp BE, Witters LA, Mimura O, Yonezawa K.

Genes Cells. 2003 Jan;8(1):65-79.

10.

Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR.

Williamson DL, Bolster DR, Kimball SR, Jefferson LS.

Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E80-9.

11.

The AMP-activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-b-D-ribonucleoside, regulates lactate production in rat Sertoli cells.

Galardo MN, Riera MF, Pellizzari EH, Cigorraga SB, Meroni SB.

J Mol Endocrinol. 2007 Oct;39(4):279-88.

PMID:
17909267
12.

Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase.

Stuck BJ, Lenski M, Böhm M, Laufs U.

J Biol Chem. 2008 Nov 21;283(47):32562-9. doi: 10.1074/jbc.M801904200. Epub 2008 Sep 12.

13.

5'-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside.

Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE.

J Biol Chem. 2001 Dec 14;276(50):46912-6. Epub 2001 Oct 11.

14.
15.

Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside.

Reiter AK, Bolster DR, Crozier SJ, Kimball SR, Jefferson LS.

Am J Physiol Endocrinol Metab. 2005 May;288(5):E980-8. Epub 2004 Dec 21.

16.
17.

[Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].

Foretz M, Taleux N, Guigas B, Horman S, Beauloye C, Andreelli F, Bertrand L, Viollet B.

Med Sci (Paris). 2006 Apr;22(4):381-8. Review. French.

18.

Role of AMP-activated protein kinase in mechanism of metformin action.

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE.

J Clin Invest. 2001 Oct;108(8):1167-74.

19.

Interaction of glibenclamide and metformin at the level of translation in pancreatic β cells.

Wang Q, Cai Y, Van de Casteele M, Pipeleers D, Ling Z.

J Endocrinol. 2011 Feb;208(2):161-9. doi: 10.1677/JOE-10-0372. Epub 2010 Nov 17.

20.

AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.

Nagata D, Takeda R, Sata M, Satonaka H, Suzuki E, Nagano T, Hirata Y.

Circulation. 2004 Jul 27;110(4):444-51. Epub 2004 Jul 19.

Supplemental Content

Support Center